Topic Archives: Extreme Alpha

Comments

  • Avatar

    Just found this in Yahoo Finance on distribution of shares between AGE and BTX. BioTime to receive $43 million from Juv...

  • Avatar

    Thank you so much for this information....

  • Avatar

    BTX Biotime, will spin off AgeX. However, one has to stretch a bit to think that the 2 parts will suddenly become vastl...

  • Avatar

    $BTX “BioTime plans to submit the Renevia application for CE Marking later this quarter with an expected approval i...

  • Avatar

    $BTX LONG 01-Feb-2018:08:19:00, BioTime, Inc. - Renevia Data from the Successful Pivotal Trial to Be Presented at ...

  • Avatar

    $BTX np and not planning to enter I have been following BTX off and on for a few years and need to preface this post ...

  • SoGiAm

    $BTX - February 3rd , 18 - Renevia(R) Data From the Successful Pivotal Trial to Be Presented at the IMCAS Conference 7:...

  • Avatar

    $BTX Bought Biotime in AH trading. Liked what I saw in all three strategic directions. Thanks Doc for your comprehen...

  • JohnM

    $aBTX np, Biotime is a long-time Patrick Cox favorite. Today's column: http://www.mauldineconomics.com/tech/tech-digest/...

  • DrKSSMDPhD

    $BTX also uses pluripotent cells, which can be turned into anything, such as retinal pigm. epithelial cell to tx dry AMD...

  • DrKSSMDPhD

    Biotime....could this one be getting ready for primetime? $BTX It owns OncoCyte and Asterias, positions each valued a...

  • JohnM

    $BTX np Dr. James Van Allen lectured for decades about the Van Allen radiation belt, the zone of energetic charged parti...

  • DrKSSMDPhD

    You sound like a $BTX long. Is there a reason you did not declare that? Or just dropping by to pump and dump? I don't...

  • Avatar

    $BTX is an alternative to CWBR. just raised $25 million, same capitalization as CWBR, spins off several biotech companie...

  • SoGiAm

    $BTX np, $CWBR 2or 3xow - Marianne, Thank YOU for sharing your excellent, prescient book review on Juvenescence. I not...

  • Avatar

    I would say Marc Lichtenfeld offered the 300,000% as a long term (retire on) potential if it was applied to all genetic...

  • DrKSSMDPhD

    Jokin: and I hope you never take one (position in $OCX). This company barely has a toe in liquid biopsy and is using tha...

  • DrKSSMDPhD

    Also, John, I attended the $BTX 30-minute corporate presentation at Noblecon13.....I definitely wasn't moved by it. I se...

  • Avatar

    $BTX np According to Mark Humayan, MD, PhD at USC Roski Eye Institute, solutions of RPE cells injected into sub-retin...

  • JohnM

    Patrick Cox pumping Asterias Biotherapeutics (AST) again. http://www.mauldineconomics.com/tech/tech-digest/the-medical-...

  • SoGiAm

    $BTX np - Article Jan 24th on BioTuesday: BioTime leading advances in regenerative medicine http://www.biotuesdays.c...

  • Avatar

    HI EYEDOC, HOW DOES OPREGN $BTX DRY AMD INJECTION COMPARE TO WET AMD, I KNOW THEY DIFFRENT EYE DISEASES HOWEVER THEIR ...

  • Avatar

    $BTX np Doc, you are correct that this would help in cases that are not amenable to anti VEGF treatment. Still..........

  • Avatar

    $BTX np This post is in response to Doc's inquiry about the OpRegen program for AMD that is being trialed in Israel a...

  • DrKSSMDPhD

    BioTime $BTX presentation Regenerative medicine programs via Asterias subsidiary: video shown of quadriplegics having...

  • DrKSSMDPhD

    I am on premises at NobleCon13. A few minutes ago, I was able to secure a tentative interview with Mr. Caruso, the CEO o...

  • Avatar

    found Dr KSS comment on BioTime #BTX via spreadsheet http://www.stockgumshoe.com/2014/07/microblog-yellow-eyes-white-po...

  • Avatar

    Thanks, Travis for sleuthing the pitch to BioTime. While the time may not be ripe to invest in BTX, it is that time o...

  • JohnM

    $BTX BioTime no position "For the first time ever, neuroscientists have treated a total quadriplegic (a 21-year-old youn...

  • Avatar

    Doc, on the topic of liquid biopsies and the large competition in that area, are you familiar with OncoCyte $OCX? $OCX i...

  • Avatar

    Hi Doc, I don't know what to say about BTX. I don't know what I'm doing and probably never should have gotten in a posi...

  • Avatar

    Biotime (BRX) subsidiary ES Cell International deal with GE Healthcare back in December. Interesting that GE Healthcare ...

  • Avatar

    On the line of using technology, I have been looking at this company BioTime (BTX) which is a stem cell company with a ...

  • Avatar

    Doc, you forgot to comment on boring old $JNJ! :) Also, would you be so kind as to comment on current BioTime $BTX and ...

  • Avatar

    Re: BTX BioTime CEO Dr. Michael D. West to Discuss BioTime's Growth, Cell-Based Therapies and Diagnostics on Bloomberg...

  • Avatar

    $BTX ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc.(BTX) and its subsidiary OncoCyte Corporation today announced the ...

  • Avatar

    Asterias Bio up 35% on massive volume. No apparent news. BioTime (BTX) owns approx. 70% of this company. Long BTX. N...

  • Avatar

    Re: BTX -- 2/24/15 BioTime Announces First Patient Treated in Pivotal Clinical Trial of Renevia™ for HIV-Associated...

  • Avatar

    BTX -- 2/17/15 Dow Jones News Headlines • BioTime Says U.S. Patent Relating to Proprietary Method Of Manufacturing...

  • Avatar

    Here's some BioTime (BTX) news on new patents, plus an unrelated new Seeking Alpha article on the company for those who ...

  • Avatar

    Stock to watch today: BioTime (BTX). Eclipsed $4/share briefly this morning and already has higher than average volume ...

  • SoGiAm

    Happy New Year Dr. KSS. and fellow Gummies. Would you be willing to discuss the science, management and interest in h...

  • Avatar

    LOL good one, Doc. I wouldn't buy AST ... I think Biotime (BTX) is the better play, as it has many irons in the fir...

  • Avatar

    Hi Doc, Is it worth looking at AST ? Asterias Biotherapeutics, member of Biotime family companies, was selected as...

  • Avatar

    Opposeable- regarding BioTime and Asterias... BioTime owns about 71% of Asterias... So by today's market cap, that's abo...

  • Avatar

    Asterias Biotherapeutics making a nice move today. I think this was part of Biotime (BTX). I know there are some Biotime...

  • Avatar

    ALAMEDA, Calif.--(BUSINESS WIRE)--Nov. 4, 2014-- BioTime, Inc. (NYSE MKT:BTX) today reported that it has received author...

  • Avatar

    BioTime, Inc. has added a news release to its Investor Relations website. Title: BioTime's Subsidiary Cell Cure Neuros...

  • Travis Johnson, Stock Gumshoe

    Cox is a lover of "cool" and of new stories, which is what newsletter subscribers really pay for -- that doesn't mean al...

  • Travis Johnson, Stock Gumshoe

    He is a journalist who became a newsletter writer, and yes, his forte is science and medicine -- He spent years pumping ...

  • Avatar

    BIOTIME ANNUAL MEETING: Shareholder Letter https://materials.proxyvote.com/Approved/09066L/20140919/SHLTR_222588.PD...

  • Avatar

    Hey guys, I am in bluebird bio (BLUE) as well. Smart people are running this company and smart people are betting on the...

  • Avatar

    Hi Pockets, Yes, I agree the technicals are bullish. BTX is waking up lately and has developed a short term uptrend. ...

  • Avatar

    BioTime (BTX) subsidiary Asterias Bio (ASTY) announced that they gained approval to uplist onto the NYSE! BioTime owns ...

  • omcdac1

    http://seekingalpha.com/article/2543805-biotime-is-right-on-time-files-ind-for-amd BioTime (NYSEMKT:BTX) recently ann...

  • Avatar

    I know most of the focus will be on DRTX today, and rightly so. I'm so pissed off I sold this one when my trailing stop...

  • Avatar

    BioTime (BTX) is not traded OTC. It is traded on the AMEX and no one should have any trouble trading it in any account....

  • Avatar

    A suggestion to Alan Harris regarding his comment in #183 above that "it's hugely expensive to trade OTC from UK." Ala...

  • Avatar

    Thanks Doc and Eliott for your input re stem cell plays. I'll look into Biotime. Also seems that Stem Cells Inc. (STEM...

  • Avatar

    Lol yes, I see the good doctor beat me to it: I think BioTime (BTX) is far and away the best and brightest in this space...

  • DrKSSMDPhD

    ScotsLad: I am not averse to gaming that space a little. But one main ground rule I suggest is NO stem cell plays for ca...

  • Avatar

    For those interested in BioTime, here is a link to the recent investor presentation (slides) http://investor.biotimeinc...

  • Avatar

    Eliott and Dr KSS; Re BioTime (BTX), If I am remembering correctly from a previous thread, Dr. KSS was at a conference a...

  • Avatar

    Hi Guys, I have mentioned BioTime (BTX) previously, but I would like to highlight recent price movement. The chart was...

  • Avatar

    BioTime (BTX) subsidiary, Asterias Biotherapeutics (ASTY) is blasting off today, up 21% on 2x average volume. Last I ch...

  • Avatar

    Some Asterias Bio news (Asterias trades as ASTY. It is a subsidiary of BioTime (BTX), which I own shares of): Dose Es...

  • DrKSSMDPhD

    Hi Kris: I think the main difference between Oncocyte and Biocept is that Oncocyte is going exclusively after circulatin...

  • Avatar

    Sorry it was Lawrence who posted (#221) the link to SA article about Biotime. Credit where credit due....

  • Avatar

    Logging in after a hiatus. Thanks Elliot for the info on Biotime. Mention is made in the article in SA that you brought ...

  • Avatar

    Also, BioTime subsidiary Asterias Bio is now traded over the counter as ASTYV. I cannot find the number of shares outst...

  • Avatar

    Found this in BioTime (BTX)'s 10-Q, which I am digging through this morning "On August 7, 2014 we were notified by the ...

  • Avatar

    BioTime news: Title: BioTime, Inc. Subsidiary OncoCyte Corporation Expands Clinical Development of Bladder Cancer Diag...

  • Avatar

    Hoping this is still the current thread- I was looking for comments on GERN through all the other threads and didn't...

  • Avatar

    BioTime (BTX) is rallying strongly today and looks like it might have formed a new "higher low". Could be a big deal if...

  • Avatar

    Eliott: Yes thank you I was aware of the company and got my wires crossed when I was trying to find a symbol that could ...

  • Avatar

    Eliott: Yes thank you I was aware of the company and got my wires crossed when I was trying to find a symbol that could ...

  • Avatar

    Tom ... Dr. KSS highlighted Biotie in this article, not BioTime. Biotie trades OTC as BIOZF. It does not trade on a ma...

  • Avatar

    Thanks Eliott: My bad. So is there only OTC on Biotime or is this the symbol for international trade? NASDAQ OMX Helsin...

  • Avatar

    This is incorrect. BTX is BioTime, not Biotie....

  • DrKSSMDPhD

    Timmuggs: Asterias is a unit of Biotime (BTX). I would not suggest investing in StemCells here until it shows it has ...

  • Avatar

    Hey Tim, I've never heard of StemCells, but I do know Asterias and I did hear about them getting this money. Asterias ...

  • DrKSSMDPhD

    Elliot: the insider buying is a good point about Biotime, and yes if you are in I would stay in. I think it is an opport...

  • DrKSSMDPhD

    Elliot: we had talked some previously about BioTime. The current BioTime incarnation has nothing in common with its prio...

  • Avatar

    Yes, yes, frank of course this is understandable. I'm beginning to think I will take a small position if not simply to ...

  • Avatar

    Getting interesting here ... $5,000,000 of venture seed funding given to LifeMap Sciences (subsidiary of BioTime (BTX)) ...

  • Avatar

    The BioTime (BTX) shareholder letter is quite an interesting read if anyone is interested. This CEO is quite a good wri...

  • Avatar

    So it turned out to be a 12 hour work day for me, so I'm not sure if I'll get around to posting about BioTime (BTX) toni...

  • Avatar

    on BTX I think it’s safe to say that no one has noticed a quiet press release that came out of BioTime (NYSE: BTX...

  • Avatar

    On BTX I think it’s safe to say that no one has noticed a quiet press release that came out of BioTime (NYSE: BTX...

  • Avatar

    sorry, that CEO I mentioned is the CEO of Biotime subsidiary Asterias Biotherapeutics. He is a former Senior Executive ...

  • DrKSSMDPhD

    I think it has changed up quite a lot since then Elliott. I see that I have kind of incongruent recall about whether I l...

  • DrKSSMDPhD

    Elliott; I am not in Biotime now. It's one of those potentially really appealing companies I just haven't had time to pa...

  • Avatar

    Hey Doc, are you still in BioTime (BTX)? I did some backreading on this one and saw a post of yours on a Travis article...

  • Avatar

    BTX BioTime Inc taking off today, up 12%, anyone know why? Thanks...

  • Avatar

    To be clear from BBERG, its the Lp below (and current largest holder): Broadwood Partners Lp, Director,1, Buys 2,000,00...

  • DrKSSMDPhD

    Frenchy: Yes, I definitely think we should be following Biotime. I'd not write this company off at all. I need to refres...

  • DrKSSMDPhD

    A Biotime (BTX) insider bought 2 million shares today....

  • Avatar

    I feel like Ariadne trying to sort out the thread to save her lover--who then dumped her. A few comments on this wild a...

  • DrKSSMDPhD

    Greenfire: from what I have seen and read about ATHX, I think your opinion is quite reasonable. They had nice data at re...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info